Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Advanced Drug Delivery Reviews
|
August 26, 2003
Targeted toxins in pain
Ronald G Wiley, Douglas A Lappi
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
December 18, 2010
Cholinergic depletion in the nucleus accumbens: effects on amphetamine response and sensorimotor gating
François Laplante, Douglas A Lappi, Ron M Sullivan
Toxins
|
March 24, 2022
Saporin as a Commercial Reagent: Its Uses and Unexpected Impacts in the Biological Sciences-Tools from the Plant Kingdom
Leonardo R Ancheta, Patrick A Shramm, Raschel Bouajram, et al.
The Journal of Physiology
|
January 16, 2004
Medullary serotonergic neurones and adjacent neurones that express neurokinin-1 receptors are both involved in chemoreception in vivo
Eugene E Nattie, Aihua Li, George B Richerson, et al.
Toxins
|
March 28, 2023
Streptavidin-Saporin: Converting Biotinylated Materials into Targeted Toxins
Leonardo R Ancheta, Patrick A Shramm, Raschel Bouajram, et al.
Neuroscience Letters
|
May 12, 2004
Spinal neurons involved in the generation of at-level pain following spinal injury in the rat
Robert P Yezierski, Chen-Guang Yu, Patrick W Mantyh, et al.
Plos One
|
September 6, 2008
Targeted destruction of photosensitive retinal ganglion cells with a saporin conjugate alters the effects of light on mouse circadian rhythms
Didem Göz, Keith Studholme, Douglas A Lappi, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
February 28, 2006
Safety evaluation of intrathecal substance P-saporin, a targeted neurotoxin, in dogs
Jeffrey W Allen, Patrick W Mantyh, Kjersti Horais, et al.
Anesthesiology
|
September 21, 2013
Intrathecal substance P-saporin in the dog: distribution, safety, and spinal neurokinin-1 receptor ablation
Ashley J Wiese, Michael Rathbun, Mark T Butt, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
January 27, 2026
A proimmunotoxin nanodrug targeting AIDS-associated non-Hodgkin lymphoma
Shilin Chen, Tong Qi, Hongxu Peng, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Advanced Drug Delivery Reviews
|
August 26, 2003
Targeted toxins in pain
Ronald G Wiley, Douglas A Lappi
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
December 18, 2010
Cholinergic depletion in the nucleus accumbens: effects on amphetamine response and sensorimotor gating
François Laplante, Douglas A Lappi, Ron M Sullivan
Toxins
|
March 24, 2022
Saporin as a Commercial Reagent: Its Uses and Unexpected Impacts in the Biological Sciences-Tools from the Plant Kingdom
Leonardo R Ancheta, Patrick A Shramm, Raschel Bouajram, et al.
The Journal of Physiology
|
January 16, 2004
Medullary serotonergic neurones and adjacent neurones that express neurokinin-1 receptors are both involved in chemoreception in vivo
Eugene E Nattie, Aihua Li, George B Richerson, et al.
Toxins
|
March 28, 2023
Streptavidin-Saporin: Converting Biotinylated Materials into Targeted Toxins
Leonardo R Ancheta, Patrick A Shramm, Raschel Bouajram, et al.
Neuroscience Letters
|
May 12, 2004
Spinal neurons involved in the generation of at-level pain following spinal injury in the rat
Robert P Yezierski, Chen-Guang Yu, Patrick W Mantyh, et al.
Plos One
|
September 6, 2008
Targeted destruction of photosensitive retinal ganglion cells with a saporin conjugate alters the effects of light on mouse circadian rhythms
Didem Göz, Keith Studholme, Douglas A Lappi, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology
|
February 28, 2006
Safety evaluation of intrathecal substance P-saporin, a targeted neurotoxin, in dogs
Jeffrey W Allen, Patrick W Mantyh, Kjersti Horais, et al.
Anesthesiology
|
September 21, 2013
Intrathecal substance P-saporin in the dog: distribution, safety, and spinal neurokinin-1 receptor ablation
Ashley J Wiese, Michael Rathbun, Mark T Butt, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
January 27, 2026
A proimmunotoxin nanodrug targeting AIDS-associated non-Hodgkin lymphoma
Shilin Chen, Tong Qi, Hongxu Peng, et al.
Page
of 1